[Theoretical basis of immunosuppression in autoimmune diseases].
D000941:Antigens; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D004357:Drug Synergism; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D007109:Immunity; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D015122:Mercaptopurine; D008727:Methotrexate / Q000627:therapeutic use; D010392:Pemphigus / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy
D000941:Antigens; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate
Theoretische Grundlagen der Immunsuppression bei Autoimmunkrankheiten.